Journal
TRENDS IN CARDIOVASCULAR MEDICINE
Volume 30, Issue 4, Pages 189-195Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tcm.2019.05.006
Keywords
Renal sympathetic nerve denervation; Hypertension; Arrhythmia; Heart failure
Categories
Ask authors/readers for more resources
The role of renal sympathetic denervation (RDN) has been the topic of ongoing debate ever since the impressive initial results. The rationale of RDN is strong and supported by non-clinical studies, which lies in uncoupling the autonomic nervous crosstalk between the kidneys and the central nervous system. Since we know that cardiovascular diseases, such as hypertension, atrial, ventricular arrhythmias and heart failure (HF) are related to sympathetic (over)activity, modulation of the renal nerve activity appears to be a reasonable and attractive therapeutic target in these patients. This review will focus on the existing evidence and potential future perspectives for RDN as treatment option in cardiovascular disease. (c) 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available